InvestorsHub Logo

H2R

Followers 41
Posts 2185
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Tuesday, 05/28/2024 10:12:23 AM

Tuesday, May 28, 2024 10:12:23 AM

Post# of 931
European Marketing Authorization for LYTENAVA™ granted!

https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeuticsr-receives-european-commission-marketing

Best of luck with your investments!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News